PD-0888 Hyperfractionated re-irradiation for locally recurrent rectal cancer: A Nordic phase II trial

摘要: ConclusionPelvEx II guideline adherence is high. QA meetings led to altered target volumes in over 50% of cases, highlighting the need for real-time peer-review of delineations for LRRC. The percentage of protocol deviations also shows the need for further development of the current guideline.